These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19752236)

  • 21. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection with Francisella tularensis LVS clpB leads to an altered yet protective immune response.
    Barrigan LM; Tuladhar S; Brunton JC; Woolard MD; Chen CJ; Saini D; Frothingham R; Sempowski GD; Kawula TH; Frelinger JA
    Infect Immun; 2013 Jun; 81(6):2028-42. PubMed ID: 23529616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.
    Huntley JF; Conley PG; Rasko DA; Hagman KE; Apicella MA; Norgard MV
    Infect Immun; 2008 Aug; 76(8):3664-71. PubMed ID: 18505805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria.
    Ben Nasr A; Haithcoat J; Masterson JE; Gunn JS; Eaves-Pyles T; Klimpel GR
    J Leukoc Biol; 2006 Oct; 80(4):774-86. PubMed ID: 16857732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the putative transcriptional regulator IclR on Francisella tularensis pathogenesis.
    Mortensen BL; Fuller JR; Taft-Benz S; Kijek TM; Miller CN; Huang MT; Kawula TH
    Infect Immun; 2010 Dec; 78(12):5022-32. PubMed ID: 20921148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement Receptor 3-Mediated Inhibition of Inflammasome Priming by Ras GTPase-Activating Protein During
    Hoang KV; Rajaram MVS; Curry HM; Gavrilin MA; Wewers MD; Schlesinger LS
    Front Immunol; 2018; 9():561. PubMed ID: 29632532
    [No Abstract]   [Full Text] [Related]  

  • 28. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
    Jia Q; Horwitz MA
    Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
    [No Abstract]   [Full Text] [Related]  

  • 29. Generation and characterization of an attenuated mutant in a response regulator gene of Francisella tularensis live vaccine strain (LVS).
    Sammons-Jackson WL; McClelland K; Manch-Citron JN; Metzger DW; Bakshi CS; Garcia E; Rasley A; Anderson BE
    DNA Cell Biol; 2008 Jul; 27(7):387-403. PubMed ID: 18613792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
    Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
    Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake of serum-opsonized Francisella tularensis by macrophages can be mediated by class A scavenger receptors.
    Pierini LM
    Cell Microbiol; 2006 Aug; 8(8):1361-70. PubMed ID: 16882038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Francisella tularensis live vaccine strain folate metabolism and pseudouridine synthase gene mutants modulate macrophage caspase-1 activation.
    Ulland TK; Janowski AM; Buchan BW; Faron M; Cassel SL; Jones BD; Sutterwala FS
    Infect Immun; 2013 Jan; 81(1):201-8. PubMed ID: 23115038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis.
    Fulop M; Mastroeni P; Green M; Titball RW
    Vaccine; 2001 Aug; 19(31):4465-72. PubMed ID: 11483272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural IgM mediates complement-dependent uptake of Francisella tularensis by human neutrophils via complement receptors 1 and 3 in nonimmune serum.
    Schwartz JT; Barker JH; Long ME; Kaufman J; McCracken J; Allen LA
    J Immunol; 2012 Sep; 189(6):3064-77. PubMed ID: 22888138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
    De Pascalis R; Hahn A; Brook HM; Ryden P; Donart N; Mittereder L; Frey B; Wu TH; Elkins KL
    PLoS One; 2018; 13(5):e0198140. PubMed ID: 29799870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.
    Richard K; Mann BJ; Stocker L; Barry EM; Qin A; Cole LE; Hurley MT; Ernst RK; Michalek SM; Stein DC; Deshong P; Vogel SN
    Clin Vaccine Immunol; 2014 Feb; 21(2):212-26. PubMed ID: 24351755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucosal immunopathogenesis of Francisella tularensis.
    Metzger DW; Bakshi CS; Kirimanjeswara G
    Ann N Y Acad Sci; 2007 Jun; 1105():266-83. PubMed ID: 17395728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.
    Sebastian S; Pinkham JT; Lynch JG; Ross RA; Reinap B; Blalock LT; Conlan JW; Kasper DL
    Vaccine; 2009 Jan; 27(4):597-605. PubMed ID: 19022323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active suppression of the pulmonary immune response by Francisella tularensis Schu4.
    Bosio CM; Bielefeldt-Ohmann H; Belisle JT
    J Immunol; 2007 Apr; 178(7):4538-47. PubMed ID: 17372012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.